Generation, validation and humanisation of a novel insulin resistant cell model

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• Insulin resistance is a key factor in type 2 diabetes development.
• Obesity significantly increases the risk of type 2 diabetes, largely due to associated insulin resistance.
• Effective insulin-sensitizing agents require models that mimic obesity-related insulin resistance.

Purpose of the Study:

• To create a novel cell model of obesity-related insulin resistance.
• To investigate the molecular mechanisms underlying insulin resistance in obesity.
• To provide a platform for screening potential therapeutic compounds.

Main Methods:

• Rat hepatoma cells were cultured using serum from obese or lean rodents and obese human volunteers.
• Insulin sensitivity was assessed by monitoring an insulin-regulated gene promoter.
• The effects of pioglitazone and metformin on insulin sensitivity were evaluated.

Main Results:

• Cells cultured with obese rodent serum exhibited significantly reduced insulin sensitivity (approx. 10-fold shift).
• This induced insulin resistance was reversible upon returning to normal growth medium.
• Pioglitazone and metformin effectively prevented the development of insulin resistance.
• Serum from obese humans with diabetes also induced insulin resistance in the cells.
• No clinical marker predicted the extent of insulin resistance generated by human serum.

Conclusions:

• A novel rat hepatoma cell model for obesity-linked insulin resistance has been successfully developed.
• This model is valuable for studying the molecular basis of insulin resistance and obesity.
• The model can be used to screen for compounds to treat obesity-related insulin resistance and identify potential biomarkers.